RS
CORZ icon

R Squared’s Core Scientific CORZ Stock Holding History

R Squared’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,282
Closed -$202K – 559
2025
Q3 		$202K Buy
+11,282
New +$165K 0.09% 382
2025
Q1 		– Sell
-1,140
Closed -$16K – 558
2024
Q4 		$16K Buy
+1,140
New +$16.8K 0.02% 981

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

R Squared's CORZ Position: Q4 2025 in Review

R Squared sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 11,282 shares — an estimated $202K sold.

R Squared first reported a position in CORZ in Q4 2024 and held it in 2 quarters. The position peaked at $202K in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • R Squared reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • R Squared sold 11,282 Core Scientific shares in Q4 2025, an estimated $202K.
  • R Squared first reported a position in Core Scientific in Q4 2024 and held it in 2 quarters.
  • R Squared's Core Scientific position peaked at $202K in Q3 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on R Squared's 13F filing for Q4 2025, filed 30 Jan 2026.